Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure

NCT02590627 is registered in ClinicalTrials.gov with National Institute for Medical Research, Tanzania as lead sponsor.

NCT NCT02590627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02590627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure
Lead sponsor
National Institute for Medical Research, Tanzania
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2014
Completion date
December 31, 2015
Enrollment
509 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria